Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Oncology Institute (TOI) Receivables - Net (2020 - 2025)

Oncology Institute (TOI) has disclosed Receivables - Net for 6 consecutive years, with $59.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net rose 9.43% year-over-year to $59.6 million, compared with a TTM value of $59.6 million through Sep 2025, up 9.43%, and an annual FY2024 reading of $48.3 million, up 14.11% over the prior year.
  • Receivables - Net was $59.6 million for Q3 2025 at Oncology Institute, up from $55.7 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $59.6 million in Q3 2025 and bottomed at $20.0 million in Q4 2021.
  • Average Receivables - Net over 5 years is $44.5 million, with a median of $47.4 million recorded in 2023.
  • The sharpest move saw Receivables - Net surged 99.01% in 2022, then dropped 16.07% in 2025.
  • Year by year, Receivables - Net stood at $20.0 million in 2021, then skyrocketed by 99.01% to $39.8 million in 2022, then increased by 6.39% to $42.4 million in 2023, then rose by 14.11% to $48.3 million in 2024, then increased by 23.39% to $59.6 million in 2025.
  • Business Quant data shows Receivables - Net for TOI at $59.6 million in Q3 2025, $55.7 million in Q2 2025, and $49.3 million in Q1 2025.